Dergiler / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 2

A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter

Sayfa
610–622
Yayın Tarihi
2022-11-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This observation likely reflects earlier access to transplantation in LDLT as one of the contributing factors to preventing CKD progression.Key words: Living-donor liver transplantation, deceased-donor liver transplantation, chronic kidney disease, outcomes, mortality, graft survival

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: The progression of chronic kidney disease (CKD) in recipients of living-donor liver transplant (LDLT) compared to deceased-donor liver transplant (DDLT) has not been studied in the literature.
📊
Temel Bulgular & Veri:Materials and methods: A retrospective study was undertaken including 999 adult, single-organ, primary liver transplant recipients (218 LDLT and 781 DDLT) at 2 centers between January 2003 and December 2012, in which CKD progression and regression were evaluated within the first 3 years after transplantation.
💡
Sonuç & Katkı:This observation likely reflects earlier access to transplantation in LDLT as one of the contributing factors to preventing CKD progression.Key words: Living-donor liver transplantation, deceased-donor liver transplantation, chronic kidney disease, outcomes, mortality, graft survival
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2003 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: The progression of chronic kidney disease (CKD) in recipients of living-donor liver transplant (LDLT) compared to deceased-donor liver transplant (DDLT) has not been studied in the literature. We hypothesize that CKD stage progression in LDLT recipients is reduced compared to that of their DDLT counterparts. Materials and methods: A retrospective study was undertaken including 999 adult, single-organ, primary liver transplant recipients (218 LDLT and 781 DDLT) at 2 centers between January 2003 and December 2012, in which CKD progression and regression were evaluated within the first 3 years after transplantation. Results: Waiting time from evaluation to transplantation was significantly lower in LDLT patients compared to recipients of DDLT. CKD stage progression from preoperative transplant evaluation to transplantation was significantly greater in DDLT. Deceased-donor liver transplant recipients continued to have higher rates of clinically significant renal disease progression (from stage I–II to stage III–V) across multiple time points over the first 3 years posttransplant. Furthermore, a greater degree of CKD regression was observed in recipients of LDLT. Conclusion: It can be concluded that LDLT provides excellent graft and patient survival, significantly reducing the overall incidence of clinically significant CKD stage progression when compared to DDLT. Moreover, there is a significantly higher incidence of CKD stage regression in LDLT compared to DDLT. These observations were maintained in both high and low model for end-stage liver disease(MELD)populations. This observation likely reflects earlier access to transplantation in LDLT as one of the contributing factors to preventing CKD progression.Key words: Living-donor liver transplantation, deceased-donor liver transplantation, chronic kidney disease, outcomes, mortality, graft survival

🔖

Bu Makaleye Atıf Yap

ACARLI, K. S., YANKOL, Y., MECİT, N., KANMAZ, T., KALAYOĞLU, M., BUGEAUD, E., ZENS, T., RIZZARI, M., LEVERSON, G. E., FOLEY, D., MEZRICH, J. D., ANDAÇOĞLU, O. M., D’ALESSANDRO, A. M., FERNANDEZ, L. A. (2022). A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 2, 610–622. https://ajindex.com/articles/609309

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA et al. OPTN/SRTR 2016 annual data report: liver. American Journal of Transplantation. 2018
  2. 18 (Suppl. 1): 172-253. doi: 10.1111/ ajt.14559 2. Hu A, Liang W, Zheng Z, Guo Z, He X. Living donor vs. deceased donor liver transplantation for patients with hepatitis C virus-related diseases. Journal of Hepatology 2012
  3. 57 (6): 1228-1243. doi: 10.1016/j.jhep.2012.07.015 3. Ohe H, Hoshino J, Ozawa M. Factors affecting outcomes of liver transplantation: an analysis of OPTN/UNOS database. Clinical Transplantation 2011: 39-53. 4. Waki K, Sugawara Y, Mizuta K, Fujita H, Kadowaki T et al. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance. Clinical Transplantation 2011: 223-235. 5. Kuramitsu K, Fukumoto T, Iwasaki T, Tominaga M, Matsumoto I et al. Long-term complications after liver transplantation. Transplantation Proceedings 2014
  4. 46 (3): 797-803. doi: 10.1016/j.transproceed.2013.11.047 6. Sandal S, Almudevar A, Parajuli S, Bose A. Comparing tenyear renal outcomes in deceased donor and living donor liver transplants. Clinical Transplantation 2015
  5. 29 (12): 1140-1147. doi: 10.1111/ctr.12639 7. Sharma P, Bari K. Chronic kidney disease and related longterm complications after liver transplantation. Advances in Chronic Kidney Disease 2015
  6. 22 (5): 404-411. doi: 10.1053/j. ackd.2015.06.001 8. Longenecker JC, Estrella MM, Segev DL, Atta MG. Patterns of kidney function before and after orthotopic liver transplant: associations with length of hospital stay, progression to endstage renal disease, and mortality. Transplantation 2015
  7. 99 (12): 2556-2564. doi: 10.1097/TP.0000000000000767 9. Lamattina JC, Foley DP, Mezrich JD, Luis A Fernandez, Vijay Vidyasagar et al. Chronic kidney disease stage progression in liver transplant recipients. Clinical Journal of the American Society of Nephrology 2011
  8. 6 (8): 1851-1857. doi: 10.2215/ CJN.00650111 10. Bahirwani R, Forde KA, Mu Y, Lin F, Reese P et al. End-stage renal disease after liver transplantation in patients with pretransplant chronic kidney disease. Clinical Transplantation 2014
  9. 28 (2): 205-210. doi: 10.1111/ctr.12298 11. Kang GW, Lee IH, Ahn KS, Kim JD, Kwak SG et al. Oneyear follow-up of the changes in renal function after liver transplantation in patients without chronic kidney disease. Transplantation Proceedings 2016
  10. 48 (4): 1190-1193. doi: 10.1016/j.transpr